Phase II study of preoperative helical tomotherapy with a simultaneous integrated boost for rectal cancer

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 1, 2012, Pages 142-148

  Engels, Benedikt ^a   Tournel, Koen ^a   Everaert, Hendrik ^a   Hoorens, Anne ^a   Sermeus, Alexandra ^a   Christian, Nicolas ^a   Storme, Guy ^a   Verellen, Dirk ^a   De Ridder, Mark ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Helical tomotherapy; Image guided radiotherapy; Preoperative radiotherapy; Rectal cancer; Simultaneous integrated boost

Indexed keywords

HELICAL TOMOTHERAPY; IMAGE GUIDED RADIOTHERAPY; PREOPERATIVE RADIOTHERAPY; RECTAL CANCER; SIMULTANEOUS INTEGRATED BOOSTS;

CHEMOTHERAPY; DISEASES; INTEGRATION; MAGNETIC RESONANCE IMAGING; RADIOTHERAPY; TUMORS;

TOXICITY;

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; DEVICES; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; HYPERSENSITIVITY REACTION; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RECTUM CANCER; TOMOTHERAPY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; FLUOROURACIL; HUMANS; INTESTINE, SMALL; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY, IMAGE-GUIDED; RADIOTHERAPY, INTENSITY-MODULATED; RECTAL NEOPLASMS; RECTUM; REMISSION INDUCTION; TREATMENT OUTCOME; URINARY BLADDER;

EID: 84859817884     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.05.068     Document Type: Article

References (39)

1. J. Folkesson, H. Birgisson, and L. Pahlman Swedish Rectal Cancer Trial: Long lasting benefits from radiotherapy on survival and local recurrence rate J Clin Oncol 23 2005 5644 5650
2. T.E. Bernstein, B.H. Endreseth, and P. Romundstad Circumferential resection margin as a prognostic factor in rectal cancer Br J Surg 96 2009 1348 1357
3. C.A. Marijnen, I.D. Nagtegaal, and E. Kapiteijn Radiotherapy does not compensate for positive resection margins in rectal cancer patients: Report of a multicenter randomized trial Int J Radiat Oncol Biol Phys 55 2003 1311 1320
4. J.F. Bosset, L. Collette, and G. Calais Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 2006 1114 1123
5. J.P. Gérard, T. Conroy, and F. Bonnetain Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203 J Clin Oncol 24 2006 4620 4625
6. M. Braendengen, K.M. Tveit, and A. Berglund Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer J Clin Oncol 26 2008 3687 3694
7. R. Sauer, H. Becker, and W. Hohenberger Preoperative vs. postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
8. M.T. Guerrero Urbano, A.J. Henrys, and E.J. Adams Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels Int J Radiat Oncol Biol Phys 65 2006 907 916
9. J.J. Nuyttens, J.M. Robertson, and D. Yan The influence of small bowel motion on both a conventional three-field and intensity modulated radiation therapy (IMRT) for rectal cancer Cancer Radiother 8 2004 297 304
10. M. Guckenberger, J. Meyer, and J. Wilbert Precision required for dose-escalated treatment of spinal metastases and implications for image-guided radiation therapy (IGRT) Radiother Oncol 84 2007 56 63
11. E. Ippolito, I. Mertens, and K. Haustermans IGRT in rectal cancer Acta Oncol 47 2008 1317 1324
12. D. Verellen, M. De Ridder, and N. Linthout Innovations in image-guided radiotherapy Nat Rev Cancer 7 2007 949 960
13. D. Verellen, M. De Ridder, and G. Storme A (short) history of image-guided radiotherapy Radiother Oncol 86 2008 4 13
14. M. De Ridder, K. Tournel, and Y. Van Nieuwenhove Phase II study of preoperative helical tomotherapy for rectal cancer Int J Radiat Oncol Biol Phys 70 2008 728 734
15. B. Engels, M. De Ridder, and K. Tournel Preoperative helical tomotherapy and megavoltage computed tomography for rectal cancer: Impact on the irradiated volume of small bowel Int J Radiat Oncol Biol Phys 74 2009 1476 1480
16. K. Tournel, M. De Ridder, and B. Engels Assessment of intrafractional movement and internal motion in radiotherapy of rectal cancer using megavoltage computed tomography Int J Radiat Oncol Biol Phys 71 2008 934 939
17. MERCURY Study Group Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: Results of the MERCURY study Radiology 243 2007 132 139
18. J.K. Mac Farlane, R.D. Ryall, and R.J. Heald Mesorectal excision for rectal cancer Lancet 341 1993 457 460
19. I.D. Nagtegaal, and J.H. van Krieken The role of pathologists in the quality control of diagnosis and treatment of rectal cancer - an overview Eur J Cancer 38 2002 964 972
20. R. Marr, K. Birbeck, and J. Garvican The modern abdominoperineal excision: The next challenge after total mesorectal exicison Ann Surg 242 2005 74 82
21. C. Rödel, T. Liersch, and R.M. Hermann Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer J Clin Oncol 25 2007 110 117
22. R. Glynne-Jones, D. Sebag-Montefiore, and T.S. Maughan A phase 1 dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer Ann Oncol 17 2006 50 56
23. R. Glynne-Jones, J. Dunst, and D. Sebag-Montefiore The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: How successful have we been? Ann Oncol 17 2006 361 371
24. J.P. Machiels, L. Duck, and B. Honhon Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: The RadiOxCape study Ann Oncol 16 2005 1898 1905
25. H. Rutten, D. Sebag-Montefiori, and R. Glynne-Jones Capecitabine, oxaliplatin, radiotherapy, and excision (CORE) in patients with MRI-defined locally advanced rectal adenocarcinoma: Results of an international multicenter phase II study J Clin Oncol 24 Suppl 2006 153s
26. C.G. Willett, D.G. Duda, and E. Di Tomaso Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: A multidisciplinary phase II study J Clin Oncol 27 2009 3020 3026
27. C.P. Aschele, S. Cordio, and G. Rosati Preoperative fluorouracil (FU)-based chemoradiation with and without weekly oxaliplatin in locally advanced rectal cancer: Pathologic response analysis of the Studio Terapia Adiuvante Retto (STAR)-01 randomized phase III trial J Clin Oncol 27 Suppl 2009 170s
28. J.P. Gérard, D. Azria, and S. Gourgou-Bourgade Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase II trial ACCORD 12/0405)-Prodige 2 J Clin Oncol 28 2010 1638 1644
29. J.P. Gérard, O. Chapet, and C. Nemoz Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: The Lyon R96-02 randomized trial J Clin Oncol 22 2004 2404 2409
30. M. Mohiuddin, K. Winter, and E. Mitchell Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group trial 0012 J Clin Oncol 24 2006 650 655
31. J.E. Tepper, and A.Z. Wang Improving local control in rectal cancer: Radiation sensitizers or radiation dose? J Clin Oncol 28 2010 1623 1624
32. K. Bujko, M.P. Nowacki, and A. Nasierowska-Guttmejer Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer Br J Surg 10 2006 1215 1223
33. P.M. Jhaveri, B.S. Teh, and A.C. Paulino Helical tomotherapy significantly reduces dose to normal tissues when compared with 3D-CRT for locally advanced rectal cancer Technol Cancer Res Treat 8 2009 379 385
34. N.P. Nguyen, M. Ceizyk, and F. Almeida Effectiveness of image-guided radiotherapy for locally advanced rectal cancer Ann Surg Oncol 18 2011 380 385
35. F.G. Taylor, P. Quirke, and R.J. Heald One millimetre is the safe cut-off for magnetic resonance imaging prediction of surgical margin status in rectal cancer Br J Surg 2011 Epub ahead of print
36. P. Videhult, K. Smedh, P. Lundin, and W. Kraaz Magnetic resonance imaging for preoperative staging of rectal cancer in clinical practice: High accuracy in predicting circumferential margin with clinical benefit Colorectal Dis 9 2007 412 419
37. I.D. Nagtegaal, C.A. Marijnen, and E.K. Kranenbarg Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: Not one millimeter but two millimetres is the limit Am J Surg Pathol 26 2002 350 357
38. rd, D. Schrag, and M.R. Somerfield American Society of Clinical Oncology recommendations on adjuvant therapy for stage II colon cancer J Clin Oncol 22 2004 3408 3419
39. L. Collette, J.F. Bosset, and M. den Dulk Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: Does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group J Clin Oncol 25 2007 4379 4386